Tuberculosis affects nine million people a year worldwide and is the second leading infectious cause of death after HIV/AIDS. Although relatively uncommon in the general Canadian population, TB is a significant public health problem in aboriginal communities in the Far North and in areas within Canada’s largest cities. 

To fight this disease, it takes passionate, committed scientists and healthcare workers with a wide range of expertise. The McGill International TB Centre based at the Research Institute of the McGill University Health Centre (RI-MUHC) has succeeded in bringing together over 20 world researchers who collaborate closely to better understand, diagnose and treat TB and other mycobacterial diseases. 

The strength of our centre is that we have a diverse range of people conducting research and outreach activities, from basic biomedical research, such as the study of DNA and its relation to infection, to epidemiological clinical trials examining the cost and effectiveness of different interventions in the field,” says Dr. Marcel Behr, director of the McGill International Tuberculosis (TB) Centre, MUHC microbiologist-in-chief and associate leader of the Infectious Diseases and Immunity in Global Health Program at the RI-MUHC.
 

Click here to learn more on the McGill International TB Centre website.